Escalon Medical (Escalon Medical) ROCE % : -12.66% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Escalon Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Escalon Medical's annualized ROCE % for the quarter that ended in Dec. 2023 was -12.66%.

Escalon Medical ROCE % Historical Data

The historical data trend for Escalon Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Escalon Medical ROCE % Chart

Escalon Medical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

-7.71

-22.25

-1.17

1.62

20.71

Escalon Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-	117.24	34.16	-2.68	-12.66

Escalon Medical ROCE % Calculation

Escalon Medical's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	0.479	/	( ( (5.172 - 3.002)	+	(5.308 - 2.853) )	/ 2 )
	=	0.479	/	( (2.17	+	2.455)	/ 2 )
	=	0.479	/	2.3125
	=	20.71 %

Escalon Medical's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-0.284	/	( ( (4.928 - 2.605)	+	(4.706 - 2.544) )	/ 2 )
	=	-0.284	/	( ( 2.323	+	2.162 )	/ 2 )
	=	-0.284	/	2.2425
	=	-12.66 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Escalon Medical (OTCPK:ESMC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Escalon Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Escalon Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Escalon Medical (Escalon Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Escalon Medical Corp (OTCPK:ESMC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

435 Devon Park Drive, Suite 824, Wayne, PA, USA, 19087

Website

https://www.escalonmedical.com

Escalon Medical Corp operates in the healthcare market specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Color/Fluorescein Angiography Digital Imaging Systems, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.

Executives

David James Jacovini	director	120 PINE STREET, PHILADELPHIA PA 19106
John Dogum	director	1818 MARKET STREET, 35TH FLOOR, PHILADELPHIA PA 19103
Richard J Depiano	director	435 DEVON PARK DRIVE, SUITE 100, WAYNE PA 19087
Lisa A Napolitano	director	351 EAST CONESTOGA ROAD, WAYNE PA 19087
C Sean Closkey	director	1700 MARKET STREET, 19TH FLOOR, PHILADELPHIA PA 19103
C Todd Trusk	director	1410 RUSSELL ROAD, SUITE 100, WAYNE PA 19301
Robert Michael O'connor	officer: Chief Financial Officer	53 SORREL RUN, MT. LAUREL NJ 08054
Anthony J Coppola	director	1 NORTH NEW YORK ROAD, SMITHVILLE NJ 08205
Federman Jay L Md	director	501 N. ESSEX AVENUE, NARBERTH PA 19072
Kwan William L G	director	351 EAST CONESTOGA ROAD, WAYNE PA 19087
Mark Wallace	officer: Chief Operating Officer	565 E SWEDESFORD ROAD, STE 200, WAYNE PA 19087
Fred G Choate	director	601 DELSEA DRIVE, WASHINGTON TOWNSHIP NJ 08080
Depiano Richard J Jr	officer: President	575 E. SWEDESFORD ROAD, SUITE 100, WAYNE PA 19087
Berkowitz David	officer: Principal Accounting Officer	565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087
Mark H Karsch	officer: CFO	565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087

Escalon Medical (Escalon Medical) Headlines

From GuruFocus

Escalon Medical Corp. Reports Operating Results (10-K)

By gurufocus 10qk • 10-12-2010

Escalon Medical Corp. Reports Operating Results (10-Q)

By gurufocus • 05-15-2009

Escalon Medical Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-20-2010

Escalon Medical Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-15-2010

Escalon Medical Corp. Reports Operating Results (10-Q)

By gurufocus • 02-18-2009

Escalon Medical Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-16-2009